Hot flashes in the menopause transition

Sudden heat - and you feel alone with it?

Hot flashes are the hallmark symptom of midlife hormone change, yet they are often minimized. They can meaningfully load the body and circulation. About 75–80% of women in perimenopause experience these sudden heat waves, often with sweating and palpitations.

On average, vasomotor symptoms persist for around seven years for many women, and sometimes longer. Medically, hot flashes are more than an annoyance - they signal vasomotor instability and deserve a structured evaluation.

75–80%

of women in perimenopause experience hot flashes, on average over many years. [3]

During this phase of hormonal change, the vascular system can respond more sensitively to triggers. Understanding how midlife transition and perimenopause connect is a first step toward durable quality-of-life improvements.

The internal medicine lens

Hot flashes and vasomotor symptoms in midlife - internal medicine context

“Hot flashes are never ‘just hormones’ to me. I also look at thyroid status, inflammation markers, and cardiovascular risk - and the good news is: targeted evaluation and individualized treatment can improve how you feel.”

Hot flashes reflect altered regulation of the brain’s thermoregulatory center in the hypothalamus, driven by declining estrogen. Estrogen helps set the brain’s thermoneutral zone. When estrogen falls during the menopause transition, that zone narrows sharply. This neurovascular instability can overlap with cognitive symptoms, because overlapping systems also influence brain energy metabolism.

Small temperature shifts can then trigger a full vasomotor response: sudden vasodilation, sweating, and a rise in heart rate. From an internal medicine perspective, these episodes are not trivial - they are measurable vasomotor events with systemic impact.

Research suggests higher frequency and intensity of hot flashes may correlate with adverse cardiovascular risk markers. The nighttime pattern is especially burdensome: night sweats fragment sleep and can drive chronic fatigue.

The large SWAN cohort also offers a reassuring message: for many women, vasomotor symptoms improve substantially after the menopause transition. You are not alone, and improvement is a realistic expectation for many people.

Read more in my article on perimenopause and heart health (German).

Why Dr. Lorenz?

I clarify whether your hot flashes are primarily driven by hormonal change - or whether contributors like hyperthyroidism or infection need attention. My vascular physiology background helps me interpret vasomotor symptoms in context (see About).

My structured two-visit pathway moves from detailed history and targeted labs to a personalized plan. I am not a gynecologist - I add an internal medicine lens to gynecologic care so the whole-person picture stays in view.

What could be going on?

Differential diagnoses

Hot flashes can have causes beyond perimenopause. A structured internal medicine workup helps confirm the common explanation and rule out important alternatives.

Hyperthyroidism

Hyperthyroidism can massively increase metabolic rate. Evaluation includes TSH, free T3, and free T4. (See thyroid.)

Chronic infections

Night sweats can signal occult inflammatory or infectious processes and deserve appropriate testing when the story fits.

Medications

SSRIs or tamoxifen are known triggers for vasomotor symptoms in some patients.

Uncommon causes

In atypical courses, clinicians may consider carcinoid syndrome or pheochromocytoma - rare, but important when red flags appear.

Metabolic factors

Vasomotor symptoms can interact with weight change and metabolic shifts.

Mood & autonomic load

Severe hot flashes can worsen mood symptoms and anxiety - a loop that benefits from a medical plan, not blame.

That is why structured evaluation matters: confirm the most likely cause, and thoughtfully rule out the dangerous exceptions.

What actually helps?

Evidence-based options

This section reflects current guideline recommendations [1] .

Hormone therapy (HT) [2]

For many patients, estrogen therapy is the most effective option. Transdermal estrogen often has favorable cardiovascular risk discussions in guideline contexts. [4]

Lifestyle measures

Layered clothing, room temperature, and identifying triggers (caffeine, alcohol) can reduce burden.

Cognitive behavioral therapy (CBT)

Guidelines such as NICE discuss CBT for vasomotor symptoms when hormones are not used or not enough.

We review what the evidence supports - clearly, without overpromising.

When should you see a doctor?

Many perimenopause symptoms are benign, but the warning signs below should be evaluated promptly:

Fever without a clear source

Unintentional weight loss

Drenching night sweats without a hormonal pattern that fits

What patients say about the clarification pathway

Turning red in a board meeting out of nowhere… Dr. Lorenz also checked my thyroid and inflammatory markers.

R.

Patient, Berlin

Anonymized case example

Next step

Sudden heat that gets in the way of daily life?

I evaluate vasomotor symptoms with an internal medicine lens - hormones, thyroid, inflammation, and cardiovascular context.

The Perimenopause Clarification is a structured two-visit program with intake, targeted diagnostics, and a written care plan. Package price €490. Lab fees are billed separately by the laboratory (typically €80–280).

Medical sources

This page is not a substitute for individualized medical advice. Key clinical statements link to the sources below.

  1. [1] NICE Guideline NG23: Menopause - diagnosis and management (NICE, 2024, Leitlinie) Open source
  2. [2] The 2022 hormone therapy position statement of The North American Menopause Society (Menopause, 2022, Positionspapier) Open source
  3. [3] Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies (Menopause, 2024, Meta-Analyse) Open source
  4. [4] Global view of vasomotor symptoms and sleep disturbance in menopause: a systematic review (Climacteric, 2023, Systematic Review) Open source

Last clinically reviewed 2026-04-15. Reviewed by Dr. med. Christin Lorenz (Ärztin mit internistischem Schwerpunkt).

Join waitlist